Mereo BioPharma Group plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 17.12 M | $59.84 M | 38.69% | 2.22% |
| RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 15.31 M | $53.58 M | 0.00% | 1.99% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 9.60 M | $33.60 M | 0.68% | 1.25% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 8.72 M | $30.50 M | -10.29% | 1.13% |
| MANGROVE PARTNERS | 02/14/2025 | 8.64 M | $30.23 M | -1.07% | 1.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 6.71 M | $23.49 M | 0.00% | 0.87% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 5.10 M | $17.84 M | 0.00% | 0.66% |
| ALKEON CAPITAL MANAGEMENT LLC | 02/14/2025 | 4.70 M | $16.44 M | 0.00% | 0.61% |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 4.55 M | $15.93 M | -6.18% | 0.59% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 3.97 M | $13.88 M | -26.49% | 0.51% |
| MORGAN STANLEY | 02/14/2025 | 3.55 M | $12.44 M | 51.38% | 0.46% |
| CLEARLINE CAPITAL LP | 02/14/2025 | 3.22 M | $11.26 M | -0.82% | 0.42% |
| UBS GROUP AG | 02/14/2025 | 2.65 M | $9.27 M | 100.00% | 0.34% |
| TEJARA CAPITAL LTD | 02/10/2025 | 2.32 M | $8.11 M | -18.12% | 0.30% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.12 M | $7.42 M | 5.55% | 0.28% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.19 M | $4.16 M | -8.88% | 0.15% |
| GREAT POINT PARTNERS LLC | 02/14/2025 | 1.15 M | $4.03 M | 100.00% | 0.15% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 1.09 M | $3.80 M | 33.07% | 0.14% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 1.00 M | $3.50 M | 0.00% | 0.13% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 964.90 K | $3.38 M | 100.00% | 0.13% |
| 02/14/2025 | 890.55 K | $3.12 M | 100.00% | 0.12% | |
| MARSHALL WACE, LLP | 02/13/2025 | 866.32 K | $3.03 M | -15.77% | 0.11% |
| NEOS INVESTMENT MANAGEMENT LLC | 02/12/2025 | 824.60 K | $2.89 M | -1.27% | 0.11% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 786.95 K | $2.75 M | -7.08% | 0.10% |
| ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 779.31 K | $2.73 M | -38.18% | 0.10% |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 777.89 K | $2.72 M | 0.00% | 0.10% |
| BLUE OWL CAPITAL HOLDINGS LP | 02/14/2025 | 672.81 K | $2.35 M | -20.64% | 0.09% |
| WOODLINE PARTNERS LP | 02/14/2025 | 618.78 K | $2.17 M | 100.00% | 0.08% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 493.90 K | $1.73 M | 100.00% | 0.06% |
| ARTIA GLOBAL PARTNERS LP | 02/14/2025 | 421.36 K | $1.47 M | 0.00% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 391.59 K | $1.37 M | 1.34% | 0.05% |
| HEALTHINVEST PARTNERS AB | 02/04/2025 | 390.00 K | $1.37 M | 95.00% | 0.05% |
| MONACO ASSET MANAGEMENT SAM | 02/10/2025 | 381.47 K | $1.34 M | -0.80% | 0.05% |
| KNOTT DAVID M JR | 02/12/2025 | 331.00 K | $1.16 M | 0.00% | 0.04% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 315.00 K | $1.10 M | 80.00% | 0.04% |
| CITADEL ADVISORS LLC | 02/14/2025 | 313.95 K | $1.10 M | 141.02% | 0.04% |
| BLACKROCK, INC. | 02/07/2025 | 273.02 K | $955.57 K | 1,806.42% | 0.04% |
| KNOLL CAPITAL MANAGEMENT, LLC | 02/18/2025 | 260.47 K | $911.65 K | 0.00% | 0.03% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 237.78 K | $832.22 K | 116.15% | 0.03% |
| CANTOR FITZGERALD, L. P. | 02/14/2025 | 225.00 K | $788.09 K | 100.00% | 0.03% |
| JANE STREET GROUP, LLC | 02/14/2025 | 208.40 K | $729.40 K | 0.00% | 0.03% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 02/25/2025 | 169.98 K | $594.92 K | -14.28% | 0.02% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 129.63 K | $453.70 K | 100.00% | 0.02% |
| JANE STREET GROUP, LLC | 02/14/2025 | 120.28 K | $420.97 K | -43.96% | 0.02% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 101.90 K | $356.65 K | -35.14% | 0.01% |
| CITADEL ADVISORS LLC | 02/14/2025 | 97.30 K | $340.55 K | -14.35% | 0.01% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 94.46 K | $330.60 K | 187.85% | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 92.16 K | $322.55 K | 0.00% | 0.01% |
| CITADEL ADVISORS LLC | 02/14/2025 | 83.90 K | $293.65 K | 402.40% | 0.01% |
| J. GOLDMAN & CO LP | 02/14/2025 | 79.39 K | $277.86 K | -68.85% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mereo BioPharma Group plc institutional Ownership - FAQ's
During the previous two years, 90 institutional investors and hedge funds held shares of Mereo BioPharma Group plc. The most heavily invested institutionals were:
BFSG, LLC: 0
Cranbrook Wealth Management, LLC: 0
SIGNATUREFD, LLC: 0
JANUS HENDERSON GROUP PLC: 17.12 M
Rubric Capital Management LP: 15.31 M
Rock Springs Capital Management LP: 9.6 M
14.96% of Mereo BioPharma Group plc stock is owned by institutional investors.
Institutional investors have bought a total of 115.74 M shares in the last 24 months. This purchase volume represents approximately $300.92 M in transactions.